{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T04:54:01Z","timestamp":1775796841059,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-42118-6","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T09:38:00Z","timestamp":1772617080000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predicting the risk for distant metastasis in hypopharyngeal squamous cell carcinoma and assessing the survival benefit of induction therapy"],"prefix":"10.1038","volume":"16","author":[{"given":"Yu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junsong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhai","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tongtong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiupeng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"issue":"1","key":"42118_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA. Cancer J. Clin. 73(1), 17\u201348. https:\/\/doi.org\/10.3322\/caac.21763 (2023).","journal-title":"CA. Cancer J. Clin."},{"issue":"3","key":"42118_CR2","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/lary.24915","volume":"125","author":"JR Newman","year":"2015","unstructured":"Newman, J. R. et al. Survival trends in hypopharyngeal cancer: A population-based review. Laryngoscope 125(3), 624\u2013629. https:\/\/doi.org\/10.1002\/lary.24915 (2015).","journal-title":"Laryngoscope"},{"issue":"15","key":"42118_CR3","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1016\/j.ejca.2015.07.043","volume":"51","author":"G Gatta","year":"2015","unstructured":"Gatta, G. et al. Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study. Eur. J. Cancer. 51(15), 2130\u20132143. https:\/\/doi.org\/10.1016\/j.ejca.2015.07.043 (2015).","journal-title":"Eur. J. Cancer."},{"key":"42118_CR4","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.oraloncology.2018.09.025","volume":"86","author":"JC Garneau","year":"2018","unstructured":"Garneau, J. C., Bakst, R. L. & Miles, B. A. Hypopharyngeal cancer: A state of the art review. Oral Oncol. 86, 244\u2013250. https:\/\/doi.org\/10.1016\/j.oraloncology.2018.09.025 (2018).","journal-title":"Oral Oncol."},{"key":"42118_CR5","doi-asserted-by":"publisher","first-page":"vii252","DOI":"10.1093\/annonc\/mdq453","volume":"21","author":"JB Vermorken","year":"2010","unstructured":"Vermorken, J. B. & Specenier, P. Optimal treatment for recurrent\/metastatic head and neck cancer. Ann. Oncol. 21, vii252\u2013vii261. https:\/\/doi.org\/10.1093\/annonc\/mdq453 (2010).","journal-title":"Ann. Oncol."},{"key":"42118_CR6","doi-asserted-by":"publisher","unstructured":"Belfiore, M. P. et al. Recurrent Versus Metastatic Head and Neck Cancer: An Evolving Landscape and the Role of Immunotherapy. Biomedicines Sep. 12 (9). https:\/\/doi.org\/10.3390\/biomedicines12092080 (2024).","DOI":"10.3390\/biomedicines12092080"},{"issue":"7","key":"42118_CR7","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.oraloncology.2011.05.011","volume":"47","author":"SK Haerle","year":"2011","unstructured":"Haerle, S. K., Schmid, D. T., Ahmad, N., Hany, T. F. & Stoeckli, S. J. The value of 18F-FDG PET\/CT for the detection of distant metastases in high-risk patients with head and neck squamous cell carcinoma. Oral Oncol. 47(7), 653\u2013659. https:\/\/doi.org\/10.1016\/j.oraloncology.2011.05.011 (2011).","journal-title":"Oral Oncol."},{"issue":"1","key":"42118_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","volume":"92","author":"JP Pignon","year":"2009","unstructured":"Pignon, J. P., le Ma\u00eetre, A., Maillard, E. & Bourhis, J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients. Radiother. Oncol. 92(1), 4\u201314. https:\/\/doi.org\/10.1016\/j.radonc.2009.04.014 (2009).","journal-title":"Radiother. Oncol."},{"issue":"20","key":"42118_CR9","doi-asserted-by":"publisher","first-page":"18081","DOI":"10.1007\/s00432-023-05497-1","volume":"149","author":"M Zhang","year":"2023","unstructured":"Zhang, M. et al. A prospective phase II randomized study of docetaxel combined with lobaplatin versus TPF regimen induction chemotherapy followed by concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma. J. Cancer Res. Clin. Oncol. 149(20), 18081\u201318091. https:\/\/doi.org\/10.1007\/s00432-023-05497-1 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"42118_CR10","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.oraloncology.2019.06.015","volume":"95","author":"M Gau","year":"2019","unstructured":"Gau, M., Karabajakian, A., Reverdy, T., Neidhardt, E. M. & Fayette, J. Induction chemotherapy in head and neck cancers: Results and controversies. Oral Oncol. 95, 164\u2013169. https:\/\/doi.org\/10.1016\/j.oraloncology.2019.06.015 (2019).","journal-title":"Oral Oncol."},{"issue":"17","key":"42118_CR11","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa071028","volume":"357","author":"JB Vermorken","year":"2007","unstructured":"Vermorken, J. B. et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N. Engl. J. Med. 357(17), 1695\u2013704. https:\/\/doi.org\/10.1056\/NEJMoa071028 (2007).","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"42118_CR12","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1056\/NEJMoa070956","volume":"357","author":"MR Posner","year":"2007","unstructured":"Posner, M. R. et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N. Engl. J. Med. 357(17), 1705\u201315. https:\/\/doi.org\/10.1056\/NEJMoa070956 (2007).","journal-title":"N. Engl. J. Med."},{"issue":"25","key":"42118_CR13","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1200\/jco.2013.54.6309","volume":"32","author":"EE Cohen","year":"2014","unstructured":"Cohen, E. E. et al. Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer. J. Clin. Oncol. 32(25), 2735\u201343. https:\/\/doi.org\/10.1200\/jco.2013.54.6309 (2014).","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"42118_CR14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1056\/NEJMra1715715","volume":"382","author":"LQM Chow","year":"2020","unstructured":"Chow, L. Q. M. Head and neck cancer. N. Engl. J. Med. 382(1), 60\u201372. https:\/\/doi.org\/10.1056\/NEJMra1715715 (2020).","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"42118_CR15","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/s1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran, V. P., Gonen, M., Smith, J. J. & DeMatteo, R. P. Nomograms in oncology: more than meets the eye. Lancet Oncol. 16(4), e173\u2013e180. https:\/\/doi.org\/10.1016\/s1470-2045(14)71116-7 (2015).","journal-title":"Lancet Oncol."},{"key":"42118_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.696952","author":"S Tian","year":"2021","unstructured":"Tian, S. et al. Development and validation of a prognostic nomogram for hypopharyngeal carcinoma. Front. Oncol. https:\/\/doi.org\/10.3389\/fonc.2021.696952 (2021).","journal-title":"Front. Oncol."},{"key":"42118_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.696952","volume":"11","author":"S Tian","year":"2021","unstructured":"Tian, S. et al. Development and validation of a prognostic nomogram for hypopharyngeal carcinoma. Front. Oncol. 11, 696952. https:\/\/doi.org\/10.3389\/fonc.2021.696952 (2021).","journal-title":"Front. Oncol."},{"issue":"6","key":"42118_CR18","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1007\/s00405-021-07109-5","volume":"279","author":"H Yang","year":"2022","unstructured":"Yang, H., Zeng, M., Cao, S. & Jin, L. Nomograms predicting prognosis for locally advanced hypopharyngeal squamous cell carcinoma. European archives of oto-rhino-laryngology\u202f: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS)\u202f: affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 279(6), 3041\u20133052. https:\/\/doi.org\/10.1007\/s00405-021-07109-5 (2022).","journal-title":"European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery"},{"issue":"1","key":"42118_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07599-2","volume":"20","author":"X Tang","year":"2020","unstructured":"Tang, X. et al. A novel prognostic model predicting the long-term cancer-specific survival for patients with hypopharyngeal squamous cell carcinoma. BMC Cancer 20(1), 1095. https:\/\/doi.org\/10.1186\/s12885-020-07599-2 (2020).","journal-title":"BMC Cancer"},{"issue":"7","key":"42118_CR20","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1007\/s10147-020-01671-4","volume":"25","author":"Z Lin","year":"2020","unstructured":"Lin, Z., Lin, H. & Lin, C. Dynamic prediction of cancer-specific survival for primary hypopharyngeal squamous cell carcinoma. Int J. Clin. Oncol Jul. 25 (7), 1260\u20131269. https:\/\/doi.org\/10.1007\/s10147-020-01671-4 (2020).","journal-title":"Int J. Clin. Oncol Jul"},{"key":"42118_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.522181","volume":"10","author":"B Guo","year":"2020","unstructured":"Guo, B. et al. A nomogram for pretreatment prediction of response to induction chemotherapy in locally advanced hypopharyngeal carcinoma. Front. Oncol. 10, 522181. https:\/\/doi.org\/10.3389\/fonc.2020.522181 (2020).","journal-title":"Front. Oncol."},{"issue":"8","key":"42118_CR22","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","volume":"186","author":"S Gerstberger","year":"2023","unstructured":"Gerstberger, S., Jiang, Q. & Ganesh, K. Metastasis. Cell 186(8), 1564\u20131579. https:\/\/doi.org\/10.1016\/j.cell.2023.03.003 (2023).","journal-title":"Cell"},{"issue":"8","key":"42118_CR23","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41577-023-00836-2","volume":"23","author":"AL Correia","year":"2023","unstructured":"Correia, A. L. Locally sourced: Site-specific immune barriers to metastasis. Nat. Rev. Immunol. 23(8), 522\u2013538. https:\/\/doi.org\/10.1038\/s41577-023-00836-2 (2023).","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"42118_CR24","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.oraloncology.2012.03.013","volume":"48","author":"RP Takes","year":"2012","unstructured":"Takes, R. P. et al. Distant metastases from head and neck squamous cell carcinoma. Part I. Basic aspects. Oral Oncol. 48(9), 775\u2013779. https:\/\/doi.org\/10.1016\/j.oraloncology.2012.03.013 (2012).","journal-title":"Oral Oncol."},{"key":"42118_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040922","author":"S Alfieri","year":"2020","unstructured":"Alfieri, S. et al. Tumor biomarkers for the prediction of distant metastasis in head and neck squamous cell carcinoma. Cancers https:\/\/doi.org\/10.3390\/cancers12040922 (2020).","journal-title":"Cancers"},{"issue":"10","key":"42118_CR26","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/jnci\/djk179","volume":"99","author":"M Hashibe","year":"2007","unstructured":"Hashibe, M. et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: Pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. JNCI J. Natl. Cancer Inst. 99(10), 777\u2013789. https:\/\/doi.org\/10.1093\/jnci\/djk179 (2007).","journal-title":"JNCI J. Natl. Cancer Inst."},{"issue":"7536","key":"42118_CR27","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nature14129","volume":"517","author":"Network. CGA.","year":"2015","unstructured":"Network. CGA. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517(7536), 576\u2013582. https:\/\/doi.org\/10.1038\/nature14129 (2015).","journal-title":"Nature"},{"key":"42118_CR28","doi-asserted-by":"publisher","first-page":"6315","DOI":"10.2147\/ijgm.S301837","volume":"14","author":"V Chiruvella","year":"2021","unstructured":"Chiruvella, V. & Guddati, A. K. Analysis of race and gender disparities in mortality trends from patients diagnosed with nasopharyngeal, oropharyngeal and hypopharyngeal cancer from 2000 to 2017. Int. J. Gen. Med. 14, 6315\u20136323. https:\/\/doi.org\/10.2147\/ijgm.S301837 (2021).","journal-title":"Int. J. Gen. Med."},{"key":"42118_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14102521","author":"J-O Park","year":"2022","unstructured":"Park, J.-O. et al. Sex differences in the prevalence of head and neck cancers: A 10-year follow-up study of 10 million healthy people. Cancers https:\/\/doi.org\/10.3390\/cancers14102521 (2022).","journal-title":"Cancers"},{"issue":"3","key":"42118_CR30","doi-asserted-by":"publisher","first-page":"620","DOI":"10.7150\/jca.28554","volume":"10","author":"Y Li","year":"2019","unstructured":"Li, Y., Ou, X. & Hu, C. Prevalence and prognostic impact of synchronous distant metastases in patients with hypopharynx squamous cell carcinomas: A SEER-based study. J. Cancer 10(3), 620\u2013626. https:\/\/doi.org\/10.7150\/jca.28554 (2019).","journal-title":"J. Cancer"},{"issue":"5","key":"42118_CR31","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrc.2016.30","volume":"16","author":"A Clocchiatti","year":"2016","unstructured":"Clocchiatti, A., Cora, E., Zhang, Y. & Dotto, G. P. Sexual dimorphism in cancer. Nature reviews Cancer May. 16 (5), 330\u2013339. https:\/\/doi.org\/10.1038\/nrc.2016.30 (2016).","journal-title":"Nature reviews Cancer May"},{"issue":"23","key":"42118_CR32","first-page":"2417","volume":"3","author":"R Sch\u00fcrmann","year":"2004","unstructured":"Sch\u00fcrmann, R., Cronin, M. & Meyer, J. U. Estrogen plus progestin and colorectal cancer in postmenopausal women. The New. Engl. J. medicine Jun. 3 (23), 2417\u20132419 (2004). author reply 2417-9.","journal-title":"The New. Engl. J. medicine Jun"},{"issue":"1","key":"42118_CR33","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1634\/theoncologist.2020-0303","volume":"26","author":"AJ Rosenberg","year":"2021","unstructured":"Rosenberg, A. J. & Vokes, E. E. Optimizing treatment de-escalation in head and neck cancer: Current and future perspectives. Oncologist 26(1), 40\u201348. https:\/\/doi.org\/10.1634\/theoncologist.2020-0303 (2021).","journal-title":"Oncologist"},{"issue":"6","key":"42118_CR34","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/hed.21804","volume":"34","author":"A Coca-Pelaz","year":"2011","unstructured":"Coca-Pelaz, A., Rodrigo, J. P. & Su\u00e1rez, C. Clinicopathologic analysis and predictive factors for distant metastases in patients with head and neck squamous cell carcinomas. Head Neck 34(6), 771\u2013775. https:\/\/doi.org\/10.1002\/hed.21804 (2011).","journal-title":"Head Neck"},{"issue":"7","key":"42118_CR35","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.oraloncology.2010.02.005","volume":"46","author":"J-Y Lim","year":"2010","unstructured":"Lim, J.-Y. et al. Predictive factors of isolated distant metastasis after primary definitive surgery without systemic treatment for head and neck squamous cell carcinoma. Oral Oncol. 46(7), 504\u2013508. https:\/\/doi.org\/10.1016\/j.oraloncology.2010.02.005 (2010).","journal-title":"Oral Oncol."},{"key":"42118_CR36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.oraloncology.2018.11.023","volume":"88","author":"JC Liu","year":"2019","unstructured":"Liu, J. C., Bhayani, M., Kuchta, K., Galloway, T. & Fundakowski, C. Patterns of distant metastasis in head and neck cancer at presentation: Implications for initial evaluation. Oral Oncol. 88, 131\u2013136. https:\/\/doi.org\/10.1016\/j.oraloncology.2018.11.023 (2019).","journal-title":"Oral Oncol."},{"issue":"9","key":"42118_CR37","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/hed.24687","volume":"39","author":"F Duprez","year":"2017","unstructured":"Duprez, F. et al. Distant metastases in head and neck cancer. Head Neck 39(9), 1733\u20131743. https:\/\/doi.org\/10.1002\/hed.24687 (2017).","journal-title":"Head Neck"},{"issue":"7","key":"42118_CR38","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/1097-0347(200010)22:7<680::AID-HED7>3.0.CO;2-J","volume":"22","author":"X Le\u00f3n","year":"2000","unstructured":"Le\u00f3n, X., Quer, M., Or\u00fas, C., del Prado Venegas, M. & L\u00f3pez, M. Distant metastases in head and neck cancer patients who achieved loco-regional control. Head Neck 22(7), 680\u20136. https:\/\/doi.org\/10.1002\/1097-0347(200010)22:7<680::aid-hed7>3.0.co;2-j (2000).","journal-title":"Head Neck"},{"issue":"7","key":"42118_CR39","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/archotol.132.7.762","volume":"132","author":"W Garavello","year":"2006","unstructured":"Garavello, W., Ciardo, A., Spreafico, R. & Gaini, R. M. Risk factors for distant metastases in head and neck squamous cell carcinoma. Archives otolaryngology\u2013head & neck surgery Jul. 132 (7), 762\u2013766. https:\/\/doi.org\/10.1001\/archotol.132.7.762 (2006).","journal-title":"Archives otolaryngology\u2013head & neck surgery Jul"},{"issue":"5","key":"42118_CR40","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1002\/ijc.20740","volume":"114","author":"AL Carvalho","year":"2005","unstructured":"Carvalho, A. L., Nishimoto, I. N., Califano, J. A. & Kowalski, L. P. Trends in incidence and prognosis for head and neck cancer in the United States: A site-specific analysis of the SEER database. Int. J. Cancer 114(5), 806\u201316. https:\/\/doi.org\/10.1002\/ijc.20740 (2005).","journal-title":"Int. J. Cancer"},{"issue":"1","key":"42118_CR41","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1001\/archotol.129.1.44","volume":"129","author":"RS Weber","year":"2003","unstructured":"Weber, R. S. et al. Outcome of salvage total laryngectomy following organ preservation therapy: The Radiation Therapy Oncology Group trial 91\u2009\u2212\u200911. Arch. Otolaryngol. Head Neck Surg. 129(1), 44\u20139. https:\/\/doi.org\/10.1001\/archotol.129.1.44 (2003).","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"issue":"6","key":"42118_CR42","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1097\/00005537-200106000-00028","volume":"111","author":"JG Spector","year":"2001","unstructured":"Spector, J. G. et al. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. Laryngoscope 111(6), 1079\u201387. https:\/\/doi.org\/10.1097\/00005537-200106000-00028 (2001).","journal-title":"Laryngoscope"},{"issue":"1","key":"42118_CR43","doi-asserted-by":"publisher","first-page":"6","DOI":"10.14639\/0392-100x-n0879","volume":"41","author":"CM Chiesa-Estomba","year":"2021","unstructured":"Chiesa-Estomba, C. M. et al. Clinical and histopathological risk factors for distant metastasis in head and neck cancer patients. Acta Otorhinolaryngol. Ital. 41(1), 6\u201317. https:\/\/doi.org\/10.14639\/0392-100x-n0879 (2021).","journal-title":"Acta Otorhinolaryngol. Ital."},{"issue":"3","key":"42118_CR44","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/s1470-2045(13)70011-1","volume":"14","author":"R Haddad","year":"2013","unstructured":"Haddad, R. et al. Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): A randomised phase 3 trial. Lancet Oncol. 14(3), 257\u201364. https:\/\/doi.org\/10.1016\/s1470-2045(13)70011-1 (2013).","journal-title":"Lancet Oncol."},{"issue":"6","key":"42118_CR45","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/hed.24739","volume":"39","author":"WA Stokes","year":"2017","unstructured":"Stokes, W. A. et al. Survival impact of induction chemotherapy in advanced head and neck cancer: A National Cancer Database analysis. Head Neck 39(6), 1113\u20131121. https:\/\/doi.org\/10.1002\/hed.24739 (2017).","journal-title":"Head Neck"},{"issue":"2","key":"42118_CR46","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/ppo.0000000000000253","volume":"23","author":"L Vidal","year":"2017","unstructured":"Vidal, L., Ben Aharon, I., Limon, D., Cohen, E. & Popovtzer, A. Role of induction chemotherapy prior to chemoradiation in head and neck squamous cell cancer-systematic review and meta-analysis. Cancer J. 23(2), 79\u201383. https:\/\/doi.org\/10.1097\/ppo.0000000000000253 (2017).","journal-title":"Cancer J."},{"issue":"2","key":"42118_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-019-0599-4","volume":"20","author":"MG Ghi","year":"2019","unstructured":"Ghi, M. G. & Paccagnella, A. Therapeutic intensification and induction chemotherapy for high-risk locally advanced squamous cell carcinoma. Curr. Treat. Options Oncol. 20(2), 2. https:\/\/doi.org\/10.1007\/s11864-019-0599-4 (2019).","journal-title":"Curr. Treat. Options Oncol."},{"issue":"8","key":"42118_CR48","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1200\/jco.2014.58.6412","volume":"33","author":"SH Huang","year":"2015","unstructured":"Huang, S. H. et al. Refining American Joint Committee on Cancer\/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas. J. Clin. Oncol. 33(8), 836\u201345. https:\/\/doi.org\/10.1200\/jco.2014.58.6412 (2015).","journal-title":"J. Clin. Oncol."},{"issue":"22","key":"42118_CR49","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa031317","volume":"349","author":"AA Forastiere","year":"2003","unstructured":"Forastiere, A. A. et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N. Engl. J. Med. 349(22), 2091\u20138. https:\/\/doi.org\/10.1056\/NEJMoa031317 (2003).","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"42118_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10306-y","volume":"22","author":"X Luo","year":"2022","unstructured":"Luo, X. et al. Induction TPF followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locally advanced hypopharyngeal cancer: A preliminary analysis of a randomized phase 2 trial. BMC Cancer 22(1), 1235. https:\/\/doi.org\/10.1186\/s12885-022-10306-y (2022).","journal-title":"BMC Cancer"},{"issue":"24","key":"42118_CR51","doi-asserted-by":"publisher","first-page":"5263","DOI":"10.1002\/cncr.33212","volume":"126","author":"K Zakeri","year":"2020","unstructured":"Zakeri, K. et al. Predictive classifier for intensive treatment of head and neck cancer. Cancer 126(24), 5263\u20135273. https:\/\/doi.org\/10.1002\/cncr.33212 (2020).","journal-title":"Cancer"},{"key":"42118_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2023.103986","volume":"186","author":"H Mahdavi","year":"2023","unstructured":"Mahdavi, H. Induction chemotherapy in locally advanced head and neck cancers, is there a best choice?. Crit. Rev. Oncol. Hematol. 186, 103986. https:\/\/doi.org\/10.1016\/j.critrevonc.2023.103986 (2023).","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"42118_CR53","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/annonc\/mdt461","volume":"25","author":"R Hitt","year":"2014","unstructured":"Hitt, R. et al. A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer. Ann. Oncol. 25(1), 216\u201325. https:\/\/doi.org\/10.1093\/annonc\/mdt461 (2014).","journal-title":"Ann. Oncol."},{"issue":"10212","key":"42118_CR54","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/s0140-6736(19)32591-7","volume":"394","author":"B Burtness","year":"2019","unstructured":"Burtness, B. et al. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): A randomised, open-label, phase 3 study. Lancet 394(10212), 1915\u20131928. https:\/\/doi.org\/10.1016\/s0140-6736(19)32591-7 (2019).","journal-title":"Lancet"},{"issue":"1","key":"42118_CR55","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2017-000257","volume":"3","author":"C Leduc","year":"2018","unstructured":"Leduc, C. et al. TPF induction chemotherapy increases PD-L1 expression in tumour cells and immune cells in head and neck squamous cell carcinoma. ESMO Open 3(1), e000257. https:\/\/doi.org\/10.1136\/esmoopen-2017-000257 (2018).","journal-title":"ESMO Open"},{"key":"42118_CR56","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003747","author":"M Hecht","year":"2022","unstructured":"Hecht, M. et al. Induction chemoimmunotherapy followed by CD8 + immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancer. J. Immunother. Cancer https:\/\/doi.org\/10.1136\/jitc-2021-003747 (2022).","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"42118_CR57","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1158\/1078-0432.Ccr-23-2398","volume":"30","author":"X Ou","year":"2024","unstructured":"Ou, X. et al. Induction Toripalimab and chemotherapy for organ preservation in locally advanced laryngeal and hypopharyngeal cancer: A single-arm Phase II clinical trial. Clin. Cancer Res. 30(2), 344\u2013355. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-23-2398 (2024).","journal-title":"Clin. Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42118-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42118-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42118-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T03:59:01Z","timestamp":1775793541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42118-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["42118"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-42118-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The SEER database is a publicly accessible, open-source registry that is exempt from ethical review and does not require informed consent from patients. This non-interventional study complied with the principles of the Declaration of Helsinki. Data acquisition for the external validation cohort was reviewed and approved by the Ethics Committees of the First Affiliated Hospital of Dalian Medical University and the Affiliated Central Hospital of Dalian University of Technology (Approval no. PJ-KS-KY-2024-496, and YN2024-121-01, respectively).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}],"article-number":"11999"}}